Stage IIA Skin Melanoma Treatment With ECHO-7 Oncolytic Virus Rigvir.
ECHO-7 virus
Rigvir
case report
melanoma
oncolytic virus
peritumoral administration
virotherapy
Journal
The Permanente journal
ISSN: 1552-5775
Titre abrégé: Perm J
Pays: United States
ID NLM: 9800474
Informations de publication
Date de publication:
14 09 2022
14 09 2022
Historique:
pubmed:
12
8
2022
medline:
23
9
2022
entrez:
11
8
2022
Statut:
ppublish
Résumé
Melanoma is a global problem due to the rising numbers of skin melanoma cases. Current treatment guidelines for patients with stage IIA melanoma recommend only observation after surgery. In this report, the authors describe a patient with stage IIA skin melanoma treated with surgery and Rigvir virotherapy. Two years after the patient discovered a brown spot on the right cheek, surgery was indicated because the mass had started to ulcerate. Rigvir virotherapy was applied both before and after surgery. Observations made more than 7 years after surgery indicated no signs of disease progression. This case report illustrates an early treatment approach. Neoadjuvant treatment for early-stage melanoma is gaining more interest in both scientific and medical communities; therefore, the authors believe it is relevant to share their observations.
Identifiants
pubmed: 35950985
doi: 10.7812/TPP/21.232
pmc: PMC9683754
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
139-144Références
Oncoimmunology. 2019 Apr 3;8(7):1593806
pubmed: 31143514
J Surg Res. 2011 May 15;167(2):192-8
pubmed: 21176922
Nat Clin Pract Oncol. 2007 Feb;4(2):101-17
pubmed: 17259931
Cell. 2017 Sep 7;170(6):1055-1056
pubmed: 28886376
Eur J Pharmacol. 2018 Oct 15;837:117-126
pubmed: 30179611
BioDrugs. 2019 Oct;33(5):485-501
pubmed: 31321623
Int J Mol Sci. 2018 May 24;19(6):
pubmed: 29795011
N Engl J Med. 2017 Jun 8;376(23):2211-2222
pubmed: 28591523
Melanoma Res. 2015 Oct;25(5):421-6
pubmed: 26193376
Melanoma Res. 2017 Feb;27(1):43-49
pubmed: 27753732
Nat Rev Drug Discov. 2019 Sep;18(9):689-706
pubmed: 31292532
Cancer Immunol Res. 2015 Aug;3(8):827-35
pubmed: 26242760
Int J Oncol. 2020 Sep;57(3):609-618
pubmed: 32582963
J Clin Epidemiol. 2017 Sep;89:218-235
pubmed: 28529185
Cell. 2017 Sep 7;170(6):1109-1119.e10
pubmed: 28886381
Adv Exp Med Biol. 2017;1036:157-172
pubmed: 29275471